OPTISURE
Device
Abbott Laboratories
Total Payments
$130,689
Transactions
362
Doctors
173
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1,268 | 39 | 31 |
| 2023 | $48,505 | 77 | 47 |
| 2022 | $80,916 | 246 | 127 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $101,514 | 10 | 77.7% |
| Debt forgiveness | $21,100 | 1 | 16.1% |
| Food and Beverage | $8,075 | 351 | 6.2% |
Payments by Type
Research
$101,514
10 transactions
General
$29,175
352 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Human Use Condition Study-Fluoroscopic Evaluation of 3D Curvature of Implanted Right Ventricular Leads in Humans | Abbott Laboratories | $100,014 | 0 |
| Optisure Lead Post Approval Study | Abbott Laboratories | $1,500 | 0 |
Top Doctors Receiving Payments for OPTISURE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Baltimore, MD | $122,614 | 11 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Roslyn, NY | $326.26 | 11 |
| , MD | Cardiovascular Disease | Houston, TX | $310.30 | 23 |
| , P.A | Physician Assistant | Roslyn, NY | $249.36 | 8 |
| , M.D | Internal Medicine | Houston, TX | $233.95 | 4 |
| , M.D | Cardiovascular Disease | Boston, MA | $200.85 | 7 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Roslyn, NY | $192.33 | 5 |
| , DO | Cardiovascular Disease | Houston, TX | $159.83 | 9 |
| , M.D | Student in an Organized Health Care Education/Training Program | Houston, TX | $145.99 | 5 |
| Bruce Wilkoff | — | Cleveland, OH | $141.17 | 1 |
| , M.D | Cardiovascular Disease | Texas City, TX | $137.26 | 2 |
| , M.D | Student in an Organized Health Care Education/Training Program | Las Vegas, NV | $135.75 | 1 |
| , RN,APRN,ACNP | General Practice | Houston, TX | $135.15 | 5 |
| , M.D | Clinical Cardiac Electrophysiology | Phoenix, AZ | $127.03 | 5 |
| , DO | Ophthalmology | Macon, GA | $126.23 | 2 |
| , M.D | Cardiovascular Disease | Houston, TX | $122.56 | 2 |
| , MD | Internal Medicine | Stanford, CA | $122.04 | 1 |
| , M.D | Cardiovascular Disease | White Plains, NY | $113.88 | 5 |
| , ACNP | Acute Care | Houston, TX | $110.94 | 3 |
| , M.D | Cardiovascular Disease | Little Rock, AR | $106.95 | 5 |
| , MD | Internal Medicine | Houston, TX | $103.79 | 7 |
| , M.D | Clinical Cardiac Electrophysiology | Houston, TX | $103.55 | 3 |
| , M.D | Internal Medicine | Cleveland, OH | $101.90 | 2 |
| , MD | Internal Medicine | Webster, TX | $96.18 | 1 |
| , M.D | Internal Medicine | Houston, TX | $92.96 | 1 |
Ad
Manufacturing Companies
- Abbott Laboratories $130,689
Product Information
- Type Device
- Total Payments $130,689
- Total Doctors 173
- Transactions 362
About OPTISURE
OPTISURE is a device associated with $130,689 in payments to 173 healthcare providers, recorded across 362 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2022 to 2024. In 2024, $1,268 was paid across 39 transactions to 31 doctors.
The most common payment nature for OPTISURE is "Unspecified" ($101,514, 77.7% of total).
OPTISURE is associated with 2 research studies, including "Human Use Condition Study-Fluoroscopic Evaluation of 3D Curvature of Implanted Right Ventricular Leads in Humans" ($100,014).